|
CN112190589A
|
|
Application of fidaxomicin in preparation of product for inhibiting activity of mycobacterium avium
|
|
CN112094348A
|
|
Anti-human Tim3 antibody or functional fragment thereof and application thereof
|
|
CN111870594A
|
|
Application of phenelzine in preparation of drug for resisting mycobacterium fortuitum infection
|
|
CN111789831A
|
|
Application of phenelzine in preparation of medicine for resisting mycobacterium abscessus infection
|
|
CN111840509A
|
|
Application of Nosiheptide in nontuberculous mycobacterial infection
|
|
CN111814893A
|
|
Lung full-scan image EGFR mutation prediction method and system based on deep learning
|
|
CN111653334A
|
|
Medicine recommending device
|
|
CN111671526A
|
|
Pre-operation positioning particle for pulmonary nodules and positioning set thereof
|
|
CN111521817A
|
|
Method for identifying protein phosphorylation sites
|
|
CN111388683A
|
|
Application of ANXA6 expression inhibitor in preparation of medicine for treating lung cancer
|
|
CN111548417A
|
|
Bispecific human antibody of EGFRvIII and EGFR and application thereof
|
|
CN111374950A
|
|
Targeting nano-drug for treating tubercular meningitis
|
|
CN111153992A
|
|
Monoclonal antibody of mycobacterium tuberculosis LAM and application thereof
|
|
CN111234026A
|
|
Monoclonal antibody specifically binding to lipoarabinomannan and application of monoclonal antibody in mycobacterium detection
|
|
CN111197098A
|
|
Method for detecting mycobacterium tuberculosis from sputum
|
|
CN111269856A
|
|
Method for separating and/or enriching mycobacterium tuberculosis
|
|
CN111269857A
|
|
Application of Rv0253 protein in separation of mycobacterium tuberculosis
|
|
CN111184724A
|
|
Application of depazolid (LCB01-0371) in mycobacterium fortuitum infection
|
|
CN111096969A
|
|
Use of sutezolid (PNU-100480) in infection of M.avium complex
|
|
CN111057705A
|
|
Kit for extracting free nucleic acid and use method
|
